Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: a UK parallel cohort study using CPRD.

OBJECTIVES X-Linked hypophosphataemic rickets (XLH) is a rare multisystemic disease of mineral homeostasis that has a prominent skeletal phenotype. The aim of this study was to describe additional comorbidities in XLH patients compared with general population controls. METHODS The Clinical Practice Research Datalink (CPRD) GOLD was used to identify a cohort of XLH patients (1995-2016), along with a non-XLH cohort matched (1:4) on age, sex and GP practice. Using the CALIBER portal, phenotyping algorithms were used to identify the first diagnosis (and associated age) of 273 comorbid conditions during patient follow-up. Fifteen major disease categories were used and the proportion of patients having ≥1 diagnosis was compared between cohorts for each category and condition. Main analyses were repeated according to Index of Multiple Deprivation (IMD). RESULTS There were 64 and 256 patients in the XLH and non-XLH cohorts, respectively. There was increased prevalence of endocrine (OR 3.46 [95% CI: 1.44-8.31]) and neurological (OR 3.01 [95% CI: 1.41-6.44] disorders among XLH patients. Across all specific comorbidities, four were at least twice as likely to be present in XLH cases, but only depression met the Bonferroni threshold: OR 2.95 [95%CI: 1.47-5.92]. Distribution of IMD among XLH cases indicated greater deprivation than the general population. CONCLUSION We describe a higher risk of mental illness in XLH patients compared with matched controls, and greater than expected deprivation. These findings may have implications for clinical practice guidelines and decisions around health and social care provision for these patients.

[1]  S. Poyrazoglu,et al.  Nationwide Turkish Cohort Study of Hypophosphatemic Rickets , 2020, Journal of Clinical Research in Pediatric Endocrinology.

[2]  M. Marmot Social justice, human rights and health equity. , 2020, Journal of public health.

[3]  R. Lachmann,et al.  Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study , 2020, Quality of Life Research.

[4]  M. Marmot,et al.  Association between socioeconomic status and the development of mental and physical health conditions in adulthood: a multi-cohort study. , 2020, The Lancet. Public health.

[5]  J. Zwerina,et al.  Multidisciplinary patient care in X‐linked hypophosphatemic rickets: one challenge, many perspectives , 2020, Wiener Medizinische Wochenschrift.

[6]  A. Rothenbuhler,et al.  Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH). , 2020, Metabolism: clinical and experimental.

[7]  N. Shaw,et al.  Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal , 2019, Advances in Therapy.

[8]  D. Greco,et al.  Reducing socio-economic inequalities in all-cause mortality: a counterfactual mediation approach , 2019, International journal of epidemiology.

[9]  C. Cooper,et al.  Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia: A United Kingdom Real-World Data Analysis , 2019, The Journal of clinical endocrinology and metabolism.

[10]  M. Maghnie,et al.  X-linked hypophosphatemic rickets: an Italian experts’ opinion survey , 2019, Italian Journal of Pediatrics.

[11]  Spiros C. Denaxas,et al.  A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service , 2019, The Lancet. Digital health.

[12]  L. Rejnmark,et al.  Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia , 2019, Nature Reviews Nephrology.

[13]  J. S. San Martin,et al.  The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey , 2019, Journal of the Endocrine Society.

[14]  Susanne Jung,et al.  Oral symptoms and oral health-related quality of life of individuals with x-linked hypophosphatemia , 2019, Head & Face Medicine.

[15]  A. Rothenbuhler,et al.  X-linked hypophosphatemia: Management and treatment prospects. , 2019, Joint, bone, spine : revue du rhumatisme.

[16]  R. Perera,et al.  Practice variation in the use of tests in UK primary care: a retrospective analysis of 16 million tests performed over 3.3 million patient years in 2015/16 , 2018, BMC Medicine.

[17]  R. Perera,et al.  Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests , 2018, British Medical Journal.

[18]  Lauren R. Khazem Physical disability and suicide: recent advancements in understanding and future directions for consideration. , 2018, Current opinion in psychology.

[19]  R. Arbuckle,et al.  Qualitative Research to Explore the Patient Experience of X-Linked Hypophosphatemia and Evaluate the Suitability of the BPI-SF and WOMAC® as Clinical Trial End Points. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[20]  M. Marmot,et al.  Subjective social status and mortality: the English Longitudinal Study of Ageing , 2018, European Journal of Epidemiology.

[21]  M. Oddy,et al.  Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations , 2018, Journal of Inherited Metabolic Disease.

[22]  L. Smeeth,et al.  Identifying social factors amongst older individuals in linked electronic health records: An assessment in a population based study , 2017, PloS one.

[23]  R. Nunn “It’s not all in my head!” - The complex relationship between rare diseases and mental health problems , 2017, Orphanet Journal of Rare Diseases.

[24]  Y. Ben-Shlomo,et al.  The effect of social deprivation on hip fracture incidence in England has not changed over 14 years: an analysis of the English Hospital Episodes Statistics (2001–2015) , 2017, Osteoporosis International.

[25]  C. Cooper,et al.  Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia , 2016, Orphanet Journal of Rare Diseases.

[26]  K. Bhaskaran,et al.  Data Resource Profile: Clinical Practice Research Datalink (CPRD) , 2015, International journal of epidemiology.

[27]  D. Brennan,et al.  Health-related quality of life and income-related social mobility in young adults , 2014, Health and Quality of Life Outcomes.

[28]  K. Bhaskaran,et al.  Completeness and usability of ethnicity data in UK-based primary care and hospital databases , 2013, Journal of public health.

[29]  M. Krzyzanowska,et al.  BIOSOCIAL CORRELATES OF INTER-GENERATIONAL SOCIAL MOBILITY IN A BRITISH COHORT , 2013, Journal of Biosocial Science.

[30]  Marko Elovainio,et al.  American Journal of Epidemiology Original Contribution Socioeconomic Differences in Cardiometabolic Factors: Social Causation or Health-related Selection? Evidence from the Whitehall Ii Cohort Study, 1991–2004 , 2022 .

[31]  M. Marmot,et al.  Economic difficulties and physical functioning in Finnish and British employees: contribution of social and behavioural factors. , 2011, European journal of public health.

[32]  I. Holm,et al.  A clinician's guide to X‐linked hypophosphatemia , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  P. Vestergaard,et al.  Phenotype Presentation of Hypophosphatemic Rickets in Adults , 2010, Calcified Tissue International.

[34]  J. Pettifor What’s new in hypophosphataemic rickets? , 2008, European Journal of Pediatrics.

[35]  Roger Newson,et al.  Multiple—test Procedures and Smile Plots , 2003 .

[36]  S. Takeda,et al.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Meitinger,et al.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.

[38]  E. Dahl Social mobility and health: cause or effect? , 1996, BMJ.

[39]  A. Poustka,et al.  A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets , 1995, Nature Genetics.

[40]  P. Kao,et al.  Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. , 1994, The New England journal of medicine.

[41]  B. Morgenstern,et al.  HYPOPHOSPHATAEMIC RICKETS: FINAL HEIGHT AND CLINICAL SYMPTOMS IN ADULTS , 1989, The Lancet.

[42]  W. Murphy,et al.  X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. , 1989, Radiology.